Evidence map›Paper›PMID 25523356›Full record

ReviewCurrent opinion in neurobiology2015

The study of psychiatric disease genes and drugs in zebrafish.

Martin Haesemeyer, Alexander F Schier

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in neurobiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Disrupted diencephalon development and neuropeptidergic pathways in zebrafish with autism-risk mutations.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Martin HaesemeyerDepartment of Molecular and Cellular Biology, Harvard University, 16 Divinity Avenue, Room 1027, Cambridge, MA 02138, United States. Electronic address: haesemeyer@fas.harvard.edu.
Alexander F SchierDepartment of Molecular and Cellular Biology, Harvard University, 16 Divinity Avenue, Room 1027, Cambridge, MA 02138, United States; Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States; Center for Brain Science, Harvard University, Cambridge, MA 02138, United States; Harvard Stem Cell Institute, Cambridge, MA 02138, United States; FAS Center for Systems Biology, Harvard University, MA 02138, United States. Electronic address: schier@fas.harvard.edu.
Center for Systems Biology · USHarvard University · US

Funding

Genetics of Sleep in ZebrafishR01HL109525 · NHLBI · HARVARD UNIVERSITY · PI SCHIER, ALEXANDER F · 2011 to 2015
$2.1M
NHLBI NIH HHS HL10925NHLBI NIH HHS R01 HL109525
6 · The paper itself

Abstract

Mutations associated with psychiatric disease are being identified, but it remains unclear how the affected genes contribute to disease. Zebrafish is an emerging model to study psychiatric disease genes with a rich repertoire of phenotyping tools. Recent zebrafish research has uncovered potential developmental phenotypes for genes associated with psychiatric disorders, while drug screens have behaviorally characterized small molecules and identified new classes of drugs. Behavioral studies have led to promising models for endophenotypes of psychiatric diseases. While further research is needed to firmly link these models to psychiatric disorders, they are valuable tools for phenotyping genetic mutations and drugs. Recently developed tools in genome editing and in vivo imaging promise additional insights into the processes disrupted by mutations in psychiatric disease genes.

Indexed as

AnimalsAntipsychotic AgentsDisease Models, AnimalDrug Evaluation, PreclinicalEndophenotypesGenetic Predisposition to DiseaseHumansMental DisordersMutationZebrafishAntipsychotic Agents

Identifiers

PMID25523356
PMCPMC4294547
OpenAlexW2078310811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.